Public Company

AVROBIO

Transforming patients' worlds

About

At AVROBIO, we aim to halt or reverse disease with a single dose of gene therapy. Our goal is simple and powerful: We aim to enable individuals with genetic disease to live longer — free from disease progression, free from painful and debilitating symptoms and free from the burden of chronic treatment regimens.

Overview

Founded 2015
Type Public
Longevity related Yes
Location Cambridge, Massachusetts, USA

Latest News

Stock

AVRO

Join the Insiders Club.

Plain English. Every week. Free.